06/14/2026
Something significant is happening in obesity care and we want you to understand what it means.
For over a century, obesity was framed as a personal failing. A matter of willpower. Of not wanting it badly enough.
That narrative is finally changing, not because willpower suddenly works, but because science does.
GLP-1 medications are among the most impressive treatments ever developed. Not just for weight loss, but for type 2 diabetes, heart disease, sleep apnea, kidney disease, liver disease, and more. The evidence is clear and it keeps growing.
And yet, most people are more likely to have heard about the risks (many of which have been debunked) than the benefits.
Why?
Because an effective medication for obesity threatens something deeply uncomfortable: the idea that people with obesity simply didn't try hard enough.
The challenge has shifted. It's no longer "how do we help people overcome obesity?" It's "how do we help people access its treatments?"
In Canada, that access gap is real. Cost, employer coverage, and systemic barriers continue to stand between people and care they deserve.
At Obesity Matters, that's exactly what we're working to change.
Because you are not alone. And you were always meant to have access to the care that works. 💙
Read the full piece by Yoni Freedhoff - Weighty Matters
Nobody chooses to live with obesity, and previous efforts show that lifestyle changes aren’t necessarily the solution. Yoni Freedhoff, MD, explains why obesity is now a choice.
